ICAD, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.78 USD | +0.56% |
|
+21.23% | 0.00% |
| May. 15 | Transcript : ICAD, Inc., Q1 2024 Earnings Call, May 15, 2024 | |
| May. 15 | Earnings Flash (ICAD) ICAD Posts Q1 Revenue $5M, vs. Street Est of $4.4M | MT |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to iCAD, Inc. Fourth Quarte...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogramâs collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a womanâs breast anatomy from the mammogram image.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.77
USD
Average target price
4.833
USD
Spread / Average Target
+173.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 46.67M | |
| +12.18% | 228B | |
| +14.52% | 196B | |
| +17.43% | 141B | |
| +29.05% | 110B | |
| +1.37% | 65.88B | |
| +18.65% | 54.3B | |
| +7.63% | 52.39B | |
| +11.09% | 45.22B | |
| +5.01% | 37.12B |
- Stock Market
- Equities
- ICAD Stock
- News iCAD, Inc.
- Transcript : iCAD, Inc., Q4 2020 Earnings Call, Feb 24, 2021